Sanofi | SAN - Interest Income


Sanofi reported EUR33M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Aena EUR 3.38M 24.49M Dec/2025
Almirall EUR 2.71M 580K Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
AstraZeneca USD 73M 62M Mar/2026
Bayer EUR 169M 39M Dec/2025
Biogen USD 37.9M 700K Mar/2026
BMW EUR 112M 32M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Essilor EUR 48M 4M Dec/2024
Fresenius Medical Care EUR 14.62M 999K Mar/2026
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
J&J USD 2.14 237M Mar/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Mercedes-Benz AG EUR 154M 2M Dec/2025
Merck EUR 21M 6M Dec/2025
Merck USD 69M 27M Dec/2025
Pfizer USD 115M 51M Mar/2026
Philips EUR 8M 13M Dec/2025
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sanofi EUR 33M 81M Dec/2025
Sanofi EUR 60M 54M Mar/2026
SAP EUR -818M 1.34B Dec/2025